Aim: To determine the characteristics of atherosclerotic plaques (ASP) remaining after percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS), that are significantly associated with cardiovascular events (CVE), according to computed tomography angiography (CTA) data.
Material And Methods: CTA was performed in 249 ACS patients on days 3-7 of the disease (in 41 patients, on a 64-slice CT scanner, and in the rest, on a 320-slice CT scanner). CTA data of all patients were analyzed on a Vitrea workstation. Patients with at least one noncalcified atherosclerotic plaque were included.
Results: During 39.1 [18.0; 57.4] months of follow-up (from 7 days to 128 months), 71 of 249 (28.5%) ACS patients had the primary endpoint (PEP), which included non-fatal myocardial infarction, unstable angina, cardiac death, PCI, and ischemic stroke. According to the univariate Cox analysis, 14 of 30 CTA characteristics of ASP turned out to be significant predictors of achieving the PEP: the number of involved arteries (HR=1.314, CI: 1.06-1.628, p=0.013, C=0.59); the total length of ASPs (HR=1.013, CI: 1.005-1.022, p=0.002, C=0.62); the number of ASPs with obstructive stenosis (HR=1.286, CI: 1.095-1.509, p=0.002, C=0.61); the minimum density (HR=0.968, CI: 0.949-0.987, p=0.001, C=0.64); a minimum density <30 HU (HR=2.695, CI: 1.495-4.869, p=0.0009, C=0.62); the number of ASPs with a minimum density <30 HU (HR=1.391, CI: 1.186-1.633, p=0.00005, C=0.64); the number of ASPs with a minimum density ≤46 HU (HR=1.211, CI: 1.043-1.407, p=0.012, C=0.58); the presence of a low-density area <30 HU (HR=2.387, CI: 1.389-4.101, p=0.001, C=0.57); the number of atherosclerotic plaques with a low-density area <30 HU (OR=1.912, CI: 1.317-2.775, p=0.001, C=0.57); the number of atherosclerotic plaques with spotty calcifications (HR=1.384, CI: 1.134-1.688, p=0.001, C=0.59); the maximum length (HR=1.014, CI: 1.001-1.028, p=0.041, C=0.61); the maximum stenosis (HR=1.018, CI: 1.002-1.033, p=0.025, C=0.61); the presence of a low-density area ≤46 HU (HR=2.049, CI: 1.24-3.386, p=0.005, C=0.57); the number of ASPs with a low-density area ≤46 HU (HR=1.643, CI: 1.191-2.265, p=0.002, C=0.58). [HR, hazard ratio; CI, 95% confidence interval; C, Harrell's C statistics]. According to the multivariate analysis, the first 10 of the listed CTA characteristics retained their prognostic significance, while the predictive significance was found for the "total plaque burden", a conditional characteristic we first proposed, which is the sum of the areas (burden) of all plaques identified by CTA in the patient.
Conclusion: 14 CTA characteristics of ASPs in patients with ACS are significant predictors of future CVE, and 11 of them are independent of known risk factors.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.18087/cardio.2025.1.n2693 | DOI Listing |
Int J Mol Sci
March 2025
School of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, No. 1200 Cailun Road, Shanghai 201203, China.
Atherosclerosis (AS) is a disease characterised by the accumulation of atherosclerotic plaques on the inner walls of blood vessels, resulting in their narrowing. In its early stages, atherosclerosis remains asymptomatic and undetectable by conventional pathological methods. However, as the disease progresses, it can lead to a series of cardiovascular diseases, which are a leading cause of mortality among middle-aged and elderly populations worldwide.
View Article and Find Full Text PDFInt J Mol Sci
March 2025
Clinic for Radiology, University Hospital Münster, 48149 Münster, Germany.
Endothelin-1 (ET-1) levels are altered in atherosclerosis, while the roles of the endothelin receptors ETR and ETR during the pathogenesis of atherosclerosis remain unclear. Therefore, the focus of this study was to clarify how endothelin receptors are expressed in advanced human atherosclerotic plaques and how this is related to atherosclerotic risk factors. Ex vivo expression analysis was performed by quantitative real-time PCR (qRT-PCR) of 98 atherosclerotic plaques and controls that were obtained from adult patients undergoing vascular surgery.
View Article and Find Full Text PDFInt J Mol Sci
February 2025
Second Department of Cardiology, Medical School, Hippokration General Hospital, Aristotle University of Thessaloniki, Konstantinoupoleos 49, 54124 Thessaloniki, Greece.
The global rise in diabetes prevalence has significantly contributed to the increasing burden of atherosclerotic cardiovascular disease (ASCVD), a leading cause of morbidity and mortality in this population. Diabetes accelerates atherosclerosis through mechanisms such as hyperglycemia, oxidative stress, chronic inflammation, and epigenetic dysregulation, leading to unstable plaques and an elevated risk of cardiovascular events. Despite advancements in controlling traditional risk factors like dyslipidemia and hypertension, a considerable residual cardiovascular risk persists, highlighting the need for innovative therapeutic approaches.
View Article and Find Full Text PDFInt J Mol Sci
February 2025
LR99E10 Human Genetics Laboratory, Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis 1002, Tunisia.
Cellular phenotypic transformation is a key process that occurs during the development and progression of atherosclerosis. Within the arterial wall, endothelial cells, vascular smooth muscle cells, and macrophages undergo phenotypic changes that contribute to the pathogenesis of atherosclerosis. miRNAs have emerged as potential biomarkers for cellular phenotypic changes during atherosclerosis.
View Article and Find Full Text PDFSci Rep
March 2025
Division of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital, Tsuchiura, Ibaraki, Japan.
Although studies have reported various patterns of atherosclerotic aortic plaques (AAPs) detected by non-obstructive aortic angioscopy (NOA), the long-term outcomes associated with AAPs such as puff-chandelier rupture atheromatous plaque (PCR), remain unclear. This study investigated the long-term prognostic significance of AAPs detected by NOA in patients who underwent percutaneous coronary intervention (PCI). This retrospective multicenter cohort study included 167 patients who underwent PCI and NOA.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!